The update of the 2021 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Guidelines for the Treatment of Infections Caused by Multidrug-Resistant Gram-Negative Bacilli
Key facts
Chair(s): Mical Paul, Israel
Approval date: February 2025
Expected completion: April 2026
Comment: Last status report date: February 2026
Status Report
Guideline Development Steps
Status
Guideline Group Membership
Completed
Establishing Guideline Group Processes
Completed
Identifying Target Audience and Topic Selection
Completed
Consumer and Stakeholder Involvement
Completed
Conflict of Interest Considerations
Completed
(PICO) Question Generation
Completed
Considering Importance of Outcomes and Interventions, Values, Preferences and Utilities
Completed
Literature Searches
Completed
Screening of Literature
Completed
Data Extraction
Ongoing
Risk of Bias Assessment
Ongoing
Summarising Evidence
Ongoing
Judging Quality, Strength or Certainty of a Body of Evidence (GRADE)
Ongoing
Developing Recommendations and Determining their Strength (EtDs)
Ongoing
Wording of Recommendations and Considerations of Implementation, Feasibility and Equity
